We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$205M
AUM Growth
-$29.7M
Cap. Flow
-$37.4M
Cap. Flow %
-18.21%
Top 10 Hldgs %
20.05%
Holding
168
New
44
Increased
17
Reduced
32
Closed
55

Top Sells

Rank Stock Value
1
GLIN icon
VanEck India Growth Leaders ETF
GLIN
+$4.44M
2
SE icon
Sea Limited
SE
+$3.57M
3
LIQT icon
LiqTech
LIQT
+$3.39M
4
CYBR
CyberArk
CYBR
+$2.93M
5
ARGX icon
argenx
ARGX
+$2.83M

Sector Composition

Rank Sector Weight
1 Technology 24.64%
2 Healthcare 22.5%
3 Industrials 15.41%
4 Consumer Discretionary 7.06%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAR icon
101
PAR Technology
PAR
$735M
$908K 0.44%
38,185
-17,166
-31% -$418K
SAFE
102
DELISTED
Safehold Inc.
SAFE
$856K 0.42%
28,060
-31,517
-53% -$960K
ACMR icon
103
ACM Research
ACMR
$5.79B
$802K 0.39%
173,523
-68,880
-28% -$362K
CSTL icon
104
Castle Biosciences
CSTL
$979M
$795K 0.39%
+43,974
New +$975K
QTRX icon
105
Quanterix
QTRX
$190M
$795K 0.39%
36,181
-16,063
-31% -$448K
VCTR icon
106
Victory Capital Holdings
VCTR
$6.65B
$795K 0.39%
51,687
-56,182
-52% -$961K
TLRA
107
DELISTED
Telaria, Inc.
TLRA
$791K 0.39%
114,482
-98,320
-46% -$817K
ENPH icon
108
Enphase Energy
ENPH
$5.53B
$787K 0.38%
35,401
-81,762
-70% -$2.1M
FATE icon
109
Fate Therapeutics
FATE
$326M
$773K 0.38%
49,796
-41,536
-45% -$796K
EHTH icon
110
eHealth
EHTH
$43.9M
$719K 0.35%
10,769
-6,898
-39% -$622K
MRTX
111
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$716K 0.35%
9,186
-15,795
-63% -$1.48M
PCTI
112
DELISTED
PCTEL, Inc. Common Stock
PCTI
$422K 0.21%
+50,280
New +$298K
PRVB
113
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$125K 0.06%
18,259
-57,532
-76% -$582K
ADVM
114
DELISTED
Adverum Biotechnologies
ADVM
-14,085
Closed -$1.68M
AIRG icon
115
Airgain
AIRG
$72.4M
-84,642
Closed -$1.2M
ANIP icon
116
ANI Pharmaceuticals
ANIP
$1.78B
-4,243
Closed -$349K
ARGX icon
117
argenx
ARGX
$54.1B
-20,025
Closed -$2.83M
ASND icon
118
Ascendis Pharma A/S
ASND
$16.8B
-23,009
Closed -$2.65M
ATEX icon
119
Anterix
ATEX
$1.94B
-23,644
Closed -$1.11M
BOOM icon
120
DMC Global
BOOM
$157M
-27,214
Closed -$1.72M
CAE icon
121
CAE Inc. Common Shares
CAE
$8.74B
-102,018
Closed -$2.75M
CDNA icon
122
CareDx
CDNA
$2.42B
-49,129
Closed -$1.77M
CDXS icon
123
Codexis
CDXS
$158M
-46,641
Closed -$860K
CLAR icon
124
Clarus
CLAR
$143M
-106,347
Closed -$1.53M
CLNE icon
125
Clean Energy Fuels
CLNE
$346M
-454,887
Closed -$1.22M

Similar funds

EAM Global Investors's Q3 2019 Portfolio in Review

As of Q3 2019, EAM Global Investors held 168 positions worth $205M, down 13% from $235M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

EAM Global Investors withdrew a net $37.4M in Q3 2019, closing 55 positions and reducing 32 holdings. Its most notable exit was Sea Limited, an estimated $3.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, EAM Global Investors opened a new position in Fly Leasing Limited worth $5.78M.

  • EAM Global Investors's largest Q3 2019 buy was Fly Leasing Limited: 281,805 shares worth $5.78M.
  • EAM Global Investors added most to Perficient Inc in Q3 2019, an estimated $1.16M increase.
  • EAM Global Investors's biggest Q3 2019 reduction was VanEck India Growth Leaders ETF, cutting an estimated $4.44M.
  • EAM Global Investors fully exited Sea Limited in Q3 2019, selling an estimated $3.57M.
  • EAM Global Investors's ten largest holdings make up 20% of its $205M portfolio in Q3 2019.
  • EAM Global Investors opened 44 new positions and closed 55 in Q3 2019.
  • EAM Global Investors's portfolio value fell 13% quarter-over-quarter to $205M.

Based on EAM Global Investors's 13F filing for Q3 2019, filed 13 Nov 2019.